These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27149710)

  • 1. [Assessment of Cachexia in Head and Neck Cancer Patients Based on a Modified Glasgow Prognostic Score].
    Matsuzuka T; Suzuki M; Saijoh S; Ikeda M; Imaizumi M; Nomoto Y; Matsui T; Tada Y; Omori K
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):125-8. PubMed ID: 27149710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
    Nakayama M; Tabuchi K; Hara A
    Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
    Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
    Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care.
    Silva GAD; Wiegert EVM; Calixto-Lima L; Oliveira LC
    Clin Nutr; 2020 May; 39(5):1587-1592. PubMed ID: 31377013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.
    Terazawa K; Ohashi T; Shibata H; Ishihara T; Ogawa T
    Head Neck; 2022 Nov; 44(11):2555-2563. PubMed ID: 36054630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of clinico-biological data for long-term prognosis of head and neck terminal cancer.
    Kawasaki T; Wasano K; Yamamoto S; Tomisato S; Ogawa K
    Acta Otolaryngol; 2017 Aug; 137(8):895-898. PubMed ID: 28301959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Huang JS; Chou WC; Hsieh JC
    Head Neck; 2017 Oct; 39(10):1990-1996. PubMed ID: 28688124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worse Preoperative Status Based on Inflammation and Host Immunity Is a Risk Factor for Surgical Site Infections in Colorectal Cancer Surgery.
    Sagawa M; Yoshimatsu K; Yokomizo H; Yano Y; Okayama S; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Kato H; Naritaka Y
    J Nippon Med Sch; 2017; 84(5):224-230. PubMed ID: 29142183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
    Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
    Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial.
    Grote M; Maihöfer C; Weigl M; Davies-Knorr P; Belka C
    Radiat Oncol; 2018 Nov; 13(1):215. PubMed ID: 30400971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).
    Matsuzuka T; Kiyota N; Mizusawa J; Akimoto T; Fujii M; Hasegawa Y; Iwae S; Monden N; Matsuura K; Onozawa Y; Hayashi R; Tahara M;
    Jpn J Clin Oncol; 2019 Jan; 49(1):37-41. PubMed ID: 30364985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.
    Ishihara H; Kondo T; Omae K; Takagi T; Iizuka J; Kobayashi H; Tanabe K
    Target Oncol; 2016 Oct; 11(5):605-617. PubMed ID: 27023922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.